| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |